02. November 2015 acCELLerate and CLS Cell Lines Sevice closed comprehensive lincesing deal

CLS Cell Lines Service and cCELLerate today announced a comprehensive licensing agreement. Under this agreement CLS grants acCELLerate access to its collection of human and animal cell lines for the development of cell based assays. acCELLerate will prepare assay ready cryopreserved cells from selected cell lines to become an integral part of acCELLerate’s instaCELL® biossay kits. "The access to a strictly controlled collection of authentic cell lines is key for the development of valid and relevant bioassays. We are very happy that we can use the cell lines from CLS to develop even better assays", commented Dr. Oliver Wehmeier, Managing Director of acCELLerate, the collaboration. Dr. Rosemarie Steubing, owner and manager of CLS stated: "I'm very enthusiastic about acCELLerate's technology to freeze our cells in a way that they can be instantlyused like any other assay reagent". CLS Cell Lines Service GmbH, acompany based in the Heidelberg area, owns and maintains a collection of more than 300 human and about 200 animal cell lines from different tissues and sources. The CLS cell bank represents cell lines which are well established and broadly used as well as rare cell lines which are exclusively available at CLS. CSL supplies its authentic cell lines but also protein lysates and DNA derived thereofto researchers all over the world. acCELLerate GmbH, from Hamburg, develops cell based assay kits for applications in research, safety, quality control and diagnostics. instaCELL®bioassays are all based on acCELLerate's expertise to prepare assay ready Frozen Instant Cells which can be directly used in an assay without prior cultivation or even cell counting. The kits contain all required components, assay plates, medium, reagents, controls and even the cells, all cross validated to provide the user the highest level of convenience and reliability.